MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ALNY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Alnylam Pharmaceuticals (ALNY) Ownership - Who owns Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
675 West Kendall Street
Phone
+1 617 551-8200
Employees
2500
Web
https://www.alnylam.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
30.39B
P/E Ratio
39.57
Total Cash
3.31B
Projected Growth
0.43
Total Debt
1.27B
Revenue
4.8B
Risk (Beta)
1.08
Dividend Yield
N/A
Total Cash/Share
24.72
Total Debt/Equity
N/A
Revenue/Share
34.63 USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
ALNY
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ALNY
A.I. Advisor
published General Information

General Information

a developer of therapeutics based on RNA interference

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
675 West Kendall Street
Phone
+1 617 551-8200
Employees
2500
Web
https://www.alnylam.com
Who owns Alnylam Pharmaceuticals? ALNY symbol Ownership - Tickeron.com